Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02346162 · ClinicalTrials.gov registry record · NA

PREPARE: A Randomized Trial of a Pre-pregnancy Weight Loss Intervention

A NA study, sponsored by Kaiser Permanente.

Completed
Registry status
NA
Development phase
326
Enrollment target

NCT02346162 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 326 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02346162, a NA study, has completed, sponsored by Kaiser Permanente.

COMPLETED
Registry status
NA
Development phase
326 participants
Enrollment target

Study Summary

The US obesity epidemic is being transmitted to the next generation. Growing evidence suggests that both a mothers' weight at pregnancy onset, and excessive weight gain during pregnancy, are associated with increased risk of pregnancy-related complications such as gestational diabetes and pre-eclampsia, and an increased risk that her child will become obese and face obesity-related health issues in later life. Currently, over one-third of reproductive-aged women in the U.S. are obese \[body mass index (BMI) ≥ 30\]. Our research team has shown that we can improve birth weight outcomes in babies of obese women who start a weight-management intervention program at 14 to 15 weeks of their pregnancy (soon after their first prenatal visit). However, organogenesis and metabolic programming begin early in the first trimester, well before the first prenatal visit. Therefore, waiting to address mothers' weight, physical activity, and diet quality until the first prenatal visit is not optimal. Given the need to reach overweight and obese women prior to pregnancy, and the Institute of Medicine's (IOM's) recent recommendation, based on observational studies, that women should reach a healthy weight before conceiving, this randomized clinical trial will evaluate a comprehensive preconception weight loss program.

Interventions

  • OTHER Usual Care Control
  • BEHAVIORAL Weight management

Trial Details

FieldValue
Enrollment Target 326 participants
Start Date 2015-06
Est. Completion 2019-06-21
Phase NA

Sponsor

Kaiser Permanente

294 total trials

What the Registry Record Tells You About NCT02346162

The ClinicalTrials.gov registry entry for NCT02346162 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 326 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Usual Care Control is the first listed.

NCT02346162 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02346162 about?

NCT02346162 is a clinical study titled "PREPARE: A Randomized Trial of a Pre-pregnancy Weight Loss Intervention". The US obesity epidemic is being transmitted to the next generation. Growing evidence suggests that both a mothers' weight at pregnancy onset, and excessive weight gain during pregnancy, are associated with increased risk of pregnancy-related complications such as gestational diabetes and pre-eclamp...

What is the current status of trial NCT02346162?

This trial is currently completed. It is a NA study. The enrollment target is 326 participants. The study started on 2015-06. Estimated completion is 2019-06-21.

What interventions are being tested in trial NCT02346162?

The interventions under investigation include: Usual Care Control (OTHER), Weight management (BEHAVIORAL).

Who is sponsoring clinical trial NCT02346162?

This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.